Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$937,781
-$152,874 QoQ
Shares Held
85,486
-36.3% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 220 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. KURA ranks #94 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | TWST |
Twist Bioscience Corp
|
40,732 | $4,190,508 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 |
All Filings in KURA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $937,781 | 85,486 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,090,655 | 134,152 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,946,992 | 187,391 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,002,014 | 113,222 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $606,484 | 105,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $865,246 | 131,098 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,268,297 | 145,614 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,792,540 | 91,737 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,565,205 | 124,585 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,639,346 | 311,268 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,175,320 | 151,274 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,117,727 | 232,207 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,090,957 | 197,633 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,357,795 | 274,554 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,069,462 | 327,918 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,850,945 | 281,914 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,746,372 | 95,274 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,911,814 | 181,083 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,925,580 | 208,970 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,195,380 | 117,212 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,425,855 | 116,348 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,192,870 | 112,942 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $731,518 | 22,398 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $876,457 | 28,605 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $203,652 | 12,494 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||